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Conclusions: In this ﬁrst study of Gd-DTPA2- transport into meniscal tissue,
the diffusion pattern was very similar between the meniscus and articular
cartilage, with a continuous wash-in until approximately 90 minutes after
injection. This is beneﬁcial in a clinical perspective because both structures
can be analyzed with dGEMRIC at the same time after contrast injection.
Notably, the concentration of Gd-DTPA2- was twice as high in the meniscus
as in the cartilage, as shown from the Delta R1 values. This may reﬂect that
the meniscus contains less GAG than articular cartilage, a fact supported
by several in vitro studies of canine and human meniscus. The higher
Gd-DTPA2- concentration in the meniscus could also be explained by a
larger contact are with synovial ﬂuid, i.e., that the diffusion occurs from
both sides of the meniscus. In vitro experiments with higher resolution
(higher ﬁeld strength) are needed to conﬁrm this hypothesis.
Previously, a linear dose-response relationship has been shown in femoral
knee cartilage [4]. The present study indicates that this may be true also for
the meniscus. However, the drop in T1 after contrast injection was highly
signiﬁcant already with the double dose. Our T1 data at 90 minutes after
the double dose are similar to what has been previously reported in human
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menisci by Krishnan et al. [5]. Future studies need to investigate the clinical
relevance of dGEMRIC of the meniscus. However, the preliminary data pre-
sented by us and others [5] indicate that the method is clinically feasible.
The lower T1 in lateral compared to medial meniscus was unexpected but
may reﬂect structural differences.
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Purpose: The purpose of this study was to assess the expression of ANK,
and other skeletogenic transcripts, in the tissue that most often harbors
crystals in individuals affected with idiopathic CPPD disease - the meniscus
of the knee - and to contrast our ﬁndings with those in menisci from
osteoarthritis patients without CPPD disease.
Methods: Menisci from total knee replacement (TKR) patients were ob-
tained post surgery. Tissues sections were subjected to alizarin red staining
to identify mineralized specimens and the chemical nature of the mineral
was conﬁrmed by FTIR analysis. For gene expression proﬁling, osteoarthri-
tis patient samples included 3 with CPPD deposition and 3 without CPPD
deposition. RNA was isolated from menisci by pulverization under liquid
nitrogen followed by RNA extraction using the RNeasy Lipid tissue kit (Qi-
agen). cDNA was synthesized from the isolated RNA and used in qRT-PCR
analyses using macroarrays speciﬁc for pathway analyses of osteogene-
sis and chondrogenesis transcripts (SA Biosciences). Immunohistochemical
staining for proteins whose transcripts showed differences among OA/CPPD
vs. OA menisci was performed on tissue sections from 12 TKR patients, 6 of
whom suffered from FTIR- conﬁrmed CPPD deposition.
Results: Contrary to our expectation, the expression of ANK, a gene whose
over-expression and mutation is associated with CPPD mineralization,
was not elevated in OA/CPPD menisci. Array transcripts included those
for cell growth and differentiation, extracellular matrix and cell adhesion
molecules, bone mineral metabolism, and mineralization. Among those
transcripts that displayed elevated levels of expression in OA/CPPD menisci
compared to OA menisci was osteopontin (OPN), MEPE, and MMP14.
Expression of the matrix molecules osteonectin and decorin were signiﬁ-
cantly depressed in OA/CPPD menisci vs. OA specimens, as were transcripts
important to chondrocyte differentiation, including SOX9 and CDH11. We
performed immunohistochemical analyses of OPN expression in tissue
sections from OA/CPPD vs. OA menisci. In a blind screen of OPN staining of
the sections, menisci containing CPPD crystals demonstrated signiﬁcantly
elevated expression of OPN (p<0.001).
Conclusions: Signiﬁcant differences in the expression of several skeleto-
genic genes and their products were observed in OA/CPPD menisci vs. OA
menisci, suggestive of distinct pathogenetic etiologies between the two
conditions. Furthermore, the observed expression proﬁle was consistent
with the non-endochondral ossiﬁcation nature of CPPD deposition. Of
particular interest was the fact that OA/CPPD meniscal specimens did not
express aberrant levels of ANK, but rather displayed striking differences in
the expression of OPN, a secreted phosphoprotein whose expression has
previously been shown to facilitate CPPD deposition in vitro.
